Pharmsville Co., Ltd. (KOSDAQ:318010)

Pharmsville Statistics

Total Valuation

Pharmsville has a market cap or net worth of KRW 30.95 billion. The enterprise value is -6.64 billion.

Market Cap	30.95B
Enterprise Value	-6.64B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Pharmsville has 7.73 million shares outstanding. The number of shares has decreased by -0.62% in one year.

Current Share Class	7.73M
Shares Outstanding	7.73M
Shares Change (YoY)	-0.62%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	62.88%
Owned by Institutions (%)	n/a
Float	2.01M

Valuation Ratios

The trailing PE ratio is 11.19.

PE Ratio	11.19
Forward PE	n/a
PS Ratio	2.17
PB Ratio	0.47
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.40
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	19.63

Financial Position

The company has a current ratio of 20.67, with a Debt / Equity ratio of 0.00.

Current Ratio	20.67
Quick Ratio	19.71
Debt / Equity	0.00
Debt / EBITDA	0.35
Debt / FCF	-0.06
Interest Coverage	-40.40

Financial Efficiency

Return on equity (ROE) is 4.29% and return on invested capital (ROIC) is -0.59%.

Return on Equity (ROE)	4.29%
Return on Assets (ROA)	-0.55%
Return on Invested Capital (ROIC)	-0.59%
Return on Capital Employed (ROCE)	-0.93%
Revenue Per Employee	527.36M
Profits Per Employee	102.41M
Employee Count	27
Asset Turnover	0.21
Inventory Turnover	2.29

Taxes

Income Tax	-16.34M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.49% in the last 52 weeks. The beta is 0.02, so Pharmsville's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	-29.49%
50-Day Moving Average	4,215.60
200-Day Moving Average	3,854.05
Relative Strength Index (RSI)	44.30
Average Volume (20 Days)	63,012

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmsville had revenue of KRW 14.24 billion and earned 2.77 billion in profits. Earnings per share was 357.78.

Revenue	14.24B
Gross Profit	8.98B
Operating Income	-611.75M
Pretax Income	2.75B
Net Income	2.77B
EBITDA	54.64M
EBIT	-611.75M
Earnings Per Share (EPS)	357.78

Balance Sheet

The company has 37.72 billion in cash and 19.12 million in debt, giving a net cash position of 37.70 billion or 4,878.17 per share.

Cash & Cash Equivalents	37.72B
Total Debt	19.12M
Net Cash	37.70B
Net Cash Per Share	4,878.17
Equity (Book Value)	65.42B
Book Value Per Share	8,452.22
Working Capital	38.47B

Cash Flow

In the last 12 months, operating cash flow was -324.16 million and capital expenditures -14.34 million, giving a free cash flow of -338.50 million.

Operating Cash Flow	-324.16M
Capital Expenditures	-14.34M
Free Cash Flow	-338.50M
FCF Per Share	-43.80

Margins

Gross margin is 63.06%, with operating and profit margins of -4.30% and 19.42%.

Gross Margin	63.06%
Operating Margin	-4.30%
Pretax Margin	19.32%
Profit Margin	19.42%
EBITDA Margin	0.38%
EBIT Margin	-4.30%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.49%.

Dividend Per Share	100.00
Dividend Yield	2.49%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	27.95%
Buyback Yield	0.62%
Shareholder Yield	3.10%
Earnings Yield	8.93%
FCF Yield	-1.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmsville has an Altman Z-Score of 10.55 and a Piotroski F-Score of 3.

Altman Z-Score	10.55
Piotroski F-Score	3